INS and Hypoglycemia: In other words, in contrast to what is written inTable 2 in the paper by Bhat et al [1], patientswith hypoglycemia resulting from IR-autoantibodies typically manifest laboratory findings atthe time of hypoglycemia similar to those of patients with hypoglycemia from injection ofexogenous insulin—ie, detectable levels of insulin plus suppressed C-peptide levels.